ESR1 and breast carcinoma: We used two independent ER+ patient-derived xenograft tumors [9] (Table 1) to find the optimal concentrations of the various growth factors to define a Breast Tumor Organoid Media for ER+ breast cancers (BTOM-ER) that support growth and expansion (Fig. 1a, Table 2).